Home / Stocks / Aarti Pharmalabs Limited
AARTIPHARM

Aarti Pharmalabs Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹1,024.6

Change

+11.2 (1.11%)

Open

₹1,015.55

Prev. Close

₹1,013.4

Day High

₹1,031.85

Day Low

₹991.45

Volume Analysis

Traded

501,333

Delivered

204,011

Delivery %

40.69%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Trading within 3% of its 52-week high (₹1047.0)
  • •Strong operating margin (23.0%)

Weaknesses (2)

  • •Low return on equity (8.59%)
  • •Promoter holding is falling

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,080.89 ₹1,056.37 ₹1,040.49 ₹1,015.97 ₹1,000.09 ₹975.57 ₹959.69
Fibonacci ₹1,056.37 ₹1,040.94 ₹1,031.4 ₹1,015.97 ₹1,000.54 ₹991.0 ₹975.57
Camarilla ₹1,035.71 ₹1,032.01 ₹1,028.3 ₹1,015.97 ₹1,020.9 ₹1,017.19 ₹1,013.49

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+37.68%

1 Week

+1.4%

1 Month

+21.51%

3 Months

+25.44%

6 Months

+43.68%

1 Year

+43.73%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹328.57

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

Company Overview

Sector

Healthcare

Market Cap

₹9,212 Cr

P/E (TTM)

35.4

ROE

8.59%

Book Value

₹249.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Aarti Pharmalabs Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 54/100. The strongest factor is Financial Strength (94/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week high (₹1047.0); strong operating margin (23.0%); low return on equity (8.59%); promoter holding is falling.

TopFund Score — Fundamentals Quality

54/100 — Average

Data confidence: 77/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

94

Growth

0

Valuation

38

Cash Flow

35

Corporate Governance

72

Momentum

93

Institutional Ownership

32

Business Quality

57

Risk & Volatility

55

Liquidity

74

From Screener.in

  • +Company is expected to give good quarter
  • −Stock is trading at 4.09 times its book value
  • −Promoter holding has decreased over last quarter: -3.20%
  • −Company has a low return on equity of 11.9% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 440 449 506 555 458 538 564 386 418 432 583 536 610
Expenses + 352 353 388 459 364 409 418 293 344 330 470 400 475
Operating Profit 88 96 118 96 94 129 146 93 74 102 113 136 135
OPM % 20.0% 21.0% 23.0% 17.0% 20.0% 24.0% 26.0% 24.0% 18.0% 24.0% 19.0% 25.0% 22.0%
Other Income + 1 1 2 2 4 5 -2 2 0 2 14 8 5
Interest 4 4 5 5 6 10 7 7 11 13 17 13 15
Depreciation 18 19 19 20 21 23 23 23 25 29 28 30 31
Profit before tax 67 74 96 74 72 101 115 65 39 63 82 101 95
Tax % 23.0% 29.0% 32.0% 25.0% 24.0% 26.0% 23.0% 24.0% 28.0% 24.0% 25.0% 25.0% 25.0%
Net Profit + 52 53 65 55 55 74 88 50 28 48 61 76 71
EPS in Rs 6 6 7 6 6 8 10 5 3 5 7 8 8
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -17 -5 4 21 4 20 11 -30 -9 -20 3 39 46

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 0 0 1,200 1,945 1,853 2,115 1,819 2,161
Expenses + 0 0 993 1,603 1,467 1,649 1,450 1,674
Operating Profit 0 0 207 342 386 466 369 487
OPM % — — 17.0% 18.0% 21.0% 22.0% 20.0% 23.0%
Other Income + 0 0 3 2 5 8 15 28
Interest 0 0 12 21 17 27 47 57
Depreciation 0 0 42 63 73 87 104 117
Profit before tax 0 0 155 261 300 361 233 341
Tax % 0.0% — 21.0% 26.0% 28.0% 24.0% 25.0% —
Net Profit + 0 0 122 193 217 272 175 257
EPS in Rs — — — 21 24 30 19 28
Dividend Payout % 0.0% — 0.0% 9.0% 13.0% 17.0% 18.0% —
Sales growth — — — 62 -5 14 -14 13

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 0 0 1,386 1,513 1,712 1,945 2,079 2,209
Borrowings + 0 0 338 215 285 413 754 897
Other Liabilities + 0 0 315 470 540 499 603 674
Total Liabilities 0 0 2,040 2,244 2,582 2,902 3,482 3,826
Fixed Assets + 0 0 782 926 1,033 1,137 1,437 1,604
CWIP 0 0 187 102 137 374 393 308
Investments 0 0 32 87 107 77 194 204
Other Assets + 0 0 1,038 1,130 1,305 1,315 1,457 1,709
Total Assets 0 0 2,040 2,244 2,582 2,902 3,482 3,826
Equity Capital 0 0 0 45 45 45 45 45

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 0 -44 250 216 330 262
Cash from Investing Activity + 0 0 -139 -158 -215 -412 -431
Cash from Financing Activity + 0 0 260 -163 10 65 171
Net Cash Flow 0 0 78 -71 12 -17 2
Free Cash Flow 0 0 -185 130 18 -114 -186
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 100 — -11 91 71 85 84

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 46.46% → 39.66%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 35.45% 35.24% 35.0% 35.17% 36.33% 40.81% 41.12% 42.12% 41.54% 41.1% 41.74% 43.78%
Promoters 46.46% 46.46% 46.46% 46.1% 44.65% 44.29% 43.72% 42.88% 43.1% 43.08% 42.86% 39.66%
Government 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
FII 8.17% 8.33% 7.07% 7.38% 8.64% 7.36% 7.34% 8.02% 7.69% 8.39% 8.17% 8.16%
DII 9.91% 9.97% 11.47% 11.35% 10.36% 7.53% 7.8% 6.95% 7.66% 7.4% 7.22% 8.4%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Aarti Pharmalabs Limited (this stock) 9,212 35.4 4.08 8.59%
Paras Healthcare Limited 9,284 129.0 — 13.0%
Strides Pharma Sci Ltd 9,353 16.2 2.74 20.0%
Jupiter Life Line Hosp L 9,507 50.0 5.84 13.1%
Healthcare Glob. Ent. Ltd 8,562 216.0 6.36 2.54%
Blue Jet Healthcare Ltd 9,989 70.9 — 52.1%
Yatharth Hosp & Tra C S L 10,222 53.6 5.44 10.2%

Which Mutual Funds Hold Aarti Pharmalabs Limited?

Frequently Asked Questions about Aarti Pharmalabs Limited

Community Sentiment

What are other investors saying about Aarti Pharmalabs Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.